China · Delayed Price · Currency is CNY Cowealth Medical China Statistics
Total Valuation
SHA:603122 has a market cap or net worth of CNY 4.19 billion. The enterprise value is 4.09 billion.
| Market Cap | 4.19B |
| Enterprise Value | 4.09B |
Important Dates
The last earnings date was Wednesday, October 28, 2026.
| Earnings Date | Oct 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHA:603122 has 398.05 million shares outstanding. The number of shares has decreased by -2.44% in one year.
| Current Share Class | 398.05M |
| Shares Outstanding | 398.05M |
| Shares Change (YoY) | -2.44% |
| Shares Change (QoQ) | +31.57% |
| Owned by Insiders (%) | 1.71% |
| Owned by Institutions (%) | 1.54% |
| Float | 172.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.54 |
| PB Ratio | 4.02 |
| P/TBV Ratio | 4.05 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.38 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.84, with a Debt / Equity ratio of 0.03.
| Current Ratio | 2.84 |
| Quick Ratio | 2.29 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -2.49% and return on invested capital (ROIC) is -2.58%.
| Return on Equity (ROE) | -2.49% |
| Return on Assets (ROA) | -1.02% |
| Return on Invested Capital (ROIC) | -2.58% |
| Return on Capital Employed (ROCE) | -2.31% |
| Weighted Average Cost of Capital (WACC) | 3.31% |
| Revenue Per Employee | 3.98M |
| Profits Per Employee | -167,061 |
| Employee Count | 161 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 3.00 |
Taxes
| Income Tax | -5.17M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +30.04% in the last 52 weeks. The beta is -0.17, so SHA:603122's price volatility has been lower than the market average.
| Beta (5Y) | -0.17 |
| 52-Week Price Change | +30.04% |
| 50-Day Moving Average | 12.53 |
| 200-Day Moving Average | 14.46 |
| Relative Strength Index (RSI) | 35.62 |
| Average Volume (20 Days) | 30,374,510 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:603122 had revenue of CNY 640.00 million and -26.90 million in losses. Loss per share was -0.07.
| Revenue | 640.00M |
| Gross Profit | 103.02M |
| Operating Income | -24.09M |
| Pretax Income | -31.90M |
| Net Income | -26.90M |
| EBITDA | -16.31M |
| EBIT | -24.09M |
| Loss Per Share | -0.07 |
Balance Sheet
The company has 140.34 million in cash and 35.59 million in debt, with a net cash position of 104.75 million or 0.26 per share.
| Cash & Cash Equivalents | 140.34M |
| Total Debt | 35.59M |
| Net Cash | 104.75M |
| Net Cash Per Share | 0.26 |
| Equity (Book Value) | 1.04B |
| Book Value Per Share | 2.35 |
| Working Capital | 731.43M |
Cash Flow
In the last 12 months, operating cash flow was -67.94 million and capital expenditures -11.66 million, giving a free cash flow of -79.60 million.
| Operating Cash Flow | -67.94M |
| Capital Expenditures | -11.66M |
| Depreciation & Amortization | 7.78M |
| Net Borrowing | 12.45M |
| Free Cash Flow | -79.60M |
| FCF Per Share | -0.20 |
Margins
Gross margin is 16.10%, with operating and profit margins of -3.76% and -4.20%.
| Gross Margin | 16.10% |
| Operating Margin | -3.76% |
| Pretax Margin | -4.98% |
| Profit Margin | -4.20% |
| EBITDA Margin | -2.55% |
| EBIT Margin | -3.76% |
| FCF Margin | n/a |
Dividends & Yields
SHA:603122 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 2.44% |
| Shareholder Yield | 2.44% |
| Earnings Yield | -0.63% |
| FCF Yield | -1.90% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |